This is an incredible outcome, representative of the Agency's recognition of ersodetug as a potential universal treatment for multiple forms of HI, and the high unmet need in this patient population. #EndoSky #MedSky #OncSky #RareDisease #Hyperinsulinism #TumorHI

Today we announced alignment with FDA on a streamlined design for the ongoing Phase 3 trial of ersodetug in patients with tumor hyperinsulinism (HI). Learn more: bit.ly/4mM7qVV

#MedSky #EndoSky #OncSky #TumorHI #Hyperinsulinism #RareDisease #DrugDevelopment

If you’re at #ENDO2025 join Rezolute's team today 4:30-6:30pm at the #HypoglycemiaHappyHour on top of Moscone Center North. Learn about our #InsulinReceptorModulatingAntibody ersodetug, and the growing body of evidence to treat all forms of #hyperinsulinism #PostBariatricHI #TumorHI #CongenitalHI